Abstract:
A conjugate for co-delivery of ispinesib and monomethyl auristatin E was prepared using methods of peptide synthesis and azide–alkyne cycloaddition. Cytotoxicity studies of the mentioned drug pair were performed. In vitro studies of the synthesized bimodal conjugate were conducted on prostate cancer cell lines.
Keywords:
prostate cancer, prostate specific membrane antigen, bimodal conjugates, monomethyl auristatin E, ispinesib, peptide synthesis, azide–alkyne cycloaddition.
Citation:
N. Yu. Zyk, A. Yu. Kolchanova, N. S. Volkova, A. A. Uspenskaia, D. A. Skvortsov, E. K. Beloglazkina, N. V. Zyk, A. G. Majouga, A. E. Machulkin, “A novel molecular platform for co-delivery of monomethyl auristatin E and ispinesib to prostate cancer cells”, Mendeleev Commun., 35:4 (2025), 440–443